Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
J. Aust, J. Davison, E. Perry, P. Eggleton, D. Hutchinson, J. Chalmers, C. Kelly, A. De Soyza (Newcastle upon Tyne, Gateshead, Exeter, Truro, Dundee, Barnstable, United Kingdom). Co-existent rheumatoid arthritis and non-cystic fibrosis bronchiectasis: Evidence for more severe pulmonary disease using the bronchiectasis severity index (BSI). Eur Respir J 2014; 44: Suppl. 58, 2519

Member's Comments

No comment yet.

Related content which might interest you: Rheumatoid arthritis and bronchiectasis: A multicentre study assessing pulmonary disease severity using the bronchiectasis severity index (BSI) Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections Year: 2014 Is etiology of non-cystic fibrosis bronchiectasis (NCFBE) a risk factor for severe exacerbation? Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections Year: 2014 Impact of co-morbidities on disease severity and risk of mortality in non-cystic fibrosis bronchiectasis Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives Year: 2015 Non-pulmonary comorbidities in idiopathic pulmonary fibrosis Source: International Congress 2015 – IPF: clinical aspects Year: 2015 Respiratory infections in patients with idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2009 - Idiopathic pulmonary fibrosis: concepts and mechanisms Year: 2009 Rheumatoid arthritis and comorbid chronic obstructive or interstitial pulmonary diseases: Prevalence in a population-based cohort Source: International Congress 2016 – Burden of respiratory diseases: from environmental aspects to healthcare consumption Year: 2016 Comorbidities in patients with the combined pulmonary fibrosis and emphysema syndrome (CPFE) Source: International Congress 2015 – Interstitial lung diseases II Year: 2015 Comparative analysis of the predictive utility of clinical disease severity scores for non-cystic fibrosis bronchiectasis Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014 Factors contributing to severe pneumonia in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections Year: 2014 Comparison between patients with idiopathic pulmonary fibrosis and patients with pulmonary involvement of the usual interstitial pneumonia pattern that preceded the onset of rheumatoid arthritis Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 Positive microbiology findings in non-cystic fibrosis bronchiectasis and co-morbidities Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections Year: 2016 Exacerbations in non-cystic fibrosis bronchiectasis Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections Year: 2014 DLCO predicts disease severity and mortality in patients with non-cystic fibrosis bronchiectasis Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook Year: 2015 Relationship between chronic dyspnoea and indices of disease severity in idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2001; 18: Suppl. 33, 150s Year: 2001 Tuberculosis in patients with idiopathic pulmonary fibrosis Source: International Congress 2015 – IPF: clinical aspects Year: 2015 Pulmonary nocardiosis (PN) complicating chronic pulmonary diseases Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014 Chronic obstructive pulmonary disease exacerbations: Impact of the GOLD stage or the presence of bronchiectasis on sputum microbiology Source: Annual Congress 2013 –Research questions on how viruses affect the respiratory system Year: 2013 Course of disease and cause of death in patients with idiopathic pulmonary fibrosis in Eastern Finland Source: International Congress 2015 – IPF: clinical aspects Year: 2015 Study of inflammatory markers and BODE index in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Systemic biomarkers Year: 2016 Etiologies of exacerbations of the chronic obstructive pulmonary disease in Tunisia Source: Annual Congress 2013 –Lung infections: a clinical point of view Year: 2013